Expiration date: 09/2026
Action:
the bone resorption inhibitor -bisphosphonate
Composition:
of zoledronic acid monohydrate, accessory: D-mannitol, sodium citrate dihydrate, water for injections
Indications:
hypercalcemia, metastatic bone lesions with malignant solid tumors and multiple myeloma, a form of primary postmenopausal osteoporosis